Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American College of Cardiology

• Publication date

  2002-12-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(02)02590-1PMID 12505220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs.

  2002cited by this paper
• Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial

  2001cited by this paper
• Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.

  2001cited by this paper
• Paradoxical Increase in Microvascular Resistance During Tachycardia Downstream From a Severe Stenosis in Patients With Coronary Artery Disease: Reversal by Angioplasty

  2001cited by this paper
• Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961

  2000cited by this paper
• Divergent Effects of Platelet-Endothelial Cell Adhesion Molecule-1 and β3 Integrin Blockade on Leukocyte Transmigration In Vivo1

  2000cited by this paper
• Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.

  2000cited by this paper
• Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction.

  2000cited by this paper
• Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina.

  2000cited by this paper
• Recognition of the importance of embolization in atherosclerotic vascular disease.

  2000cited by this paper
• Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and s

  1999cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction.

  1999cited by this paper
• Platelet GPIIb-IIIa blockers.

  1999cited by this paper
• Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension.

  1999cited by this paper
• A2A-adenosine receptor reserve for coronary vasodilation.

  1998cited by this paper
• Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.

  1998cited by this paper
• Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.

  1998cited by this paper
• Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.

  1998cited by this paper
• Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block

  1998cited by this paper
• Randomised placebo-controlled and balloon-angioplasty- controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

  1998cited by this paper
• Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs.

  1998cited by this paper
• Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.

  1998cited by this paper
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

  1998cited by this paper
• Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.

  1997cited by this paper
• Hyperventilation as a specific test for diagnosis of coronary artery spasm.

  1997cited by this paper
• Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.

  1997cited by this paper
• Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease.

  1997cited by this paper
• Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study.

  1996cited by this paper
• Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.

  1996cited by this paper
• Global alteration in perfusion response to increasing oxygen consumption in patients with single-vessel coronary artery disease.

  1994cited by this paper
• Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

  1994cited by this paper
• Hyperventilation-echocardiography test for the diagnosis of myocardial ischaemia at rest.

  1993cited by this paper
• Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients.

  1991cited by this paper
• Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions.

  1989cited by this paper
• Coronary effects of adenosine in conscious man.

  1989cited by this paper
• Platelet activation in unstable coronary disease.

  1986cited by this paper
• Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris.

  1985cited by this paper
• Computerized image analysis for quantitative measurement of vessel diameter from cineangiograms.

  1983cited by this paper
• Letter: S.L.E. and Klinefelter's syndrome.

  1976cited by this paper
• Mechanism of the effect of coronary artery stenosis on coronary flow in the dog.

  1975cited by this paper

• Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial

  2020cites this paper
• Impact of drug-eluting stents on left ventricular wall motion after successful reperfusion of first anterior ST elevation myocardial infarction.

  2020cites this paper
• Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris

  2018cites this paper
• Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial

  2018cites this paper
• An assessment of the use of the ABSORB bioresorbable vascular scaffold in the treatment of 'false' coronary bifurcations

  2017cites this paper
• Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role

  2016cites this paper
• The Morphology, Physiology and Pathophysiology of Coronary Microcirculation

  2016cites this paper
• CMD in Obstructive CAD

  2014cites this paper
• Modeling and Simulation of the Relationship of the Bearing Pressure and Area of Building

  2014cites this paper
• The central role of conventional 12-lead ECG for the assessment of microvascular obstruction after percutaneous myocardial revascularization.

  2014cites this paper
• Microvascular function/dysfunction downstream a coronary stenosis.

  2013cites this paper
• What accounts for the higher clinical efficacy of intracoronary abciximab?

  2013cites this paper
• Coronary microvascular dysfunction.

  2013cites this paper
• Optimal strategy for restoration and maintenance of Sinus Rhythm in patients with Rheumatic Mitral Stenosis and Atrial Fibrillation:ospective randamozied study.(1).Evaluation of the index of microcirculatory resistance in coronary artery lesions of intermediate severity(2)

  2012cites this paper
• Coronary microcirculation in effort ischemia : the roar of the rabbit

  2011cites this paper
• Therapeutic advances in myocardial microvascular resistance: unravelling the enigma.

  2010cites this paper
• Simultaneous pressure and flow velocity measurements in diagnosis and treatment of coronary artery disease

  2010cites this paper
• UvA-DARE ( Digital Academic Repository ) Simultaneous pressure and flow velocity measurements in diagnosis and treatment of coronary artery disease

  2010cites this paper
• Advances in coronary microvascular dysfunction.

  2009cites this paper
• Evaluation of acute and chronic microvascular coronary disease

  2009cites this paper
• Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial).

  2008cites this paper
• Intracoronary Abciximab Use in Patients Undergoing PCI at a Community Hospital: A Single Operator Experience

  2008cites this paper
• Beneficial effect of post-procedural abciximab in patients undergoing primary coronary angioplasty and presenting with the no-reflow phenomenon

  2008cites this paper
• Current world literature. Arrhythmias.

  2008cites this paper
• Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).

  2007cites this paper
• Rationale for intracoronary administration of abciximab

  2007cites this paper
• The rationale of metabolic treatment in ischaemic heart disease

  2007cites this paper
• Therapeutic Inhibitors of Platelet Aggregation – from Aspirin to Integrin Blockersf

  2007cites this paper
• Main clinical article Persistent angina

  2006cites this paper
• Changing scenario in chronic ischemic heart disease: therapeutic implications.

  2006cites this paper
• Effects of GP IIb/IIIa inhibitors on vascular inflammation, coronary microcirculation, and platelet function.

  2006cites this paper
• Persistent angina after myocardial revascularization: a case report

  2006cites this paper
• Inhibition of platelet activation and aggregation.

  2005cites this paper
• Correlation of Hemodynamic Events with Clinical and Pathological Observations

  2005cites this paper
• Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI.

  2005cites this paper
• Influence of Percutaneous Coronary Intervention on Coronary Microvascular Resistance Index

  2005cites this paper
• Recurrent and resistant angina: is the metabolic approach an appropriate answer?

  2004cites this paper
• Propagation of arterial thrombi: local and remote contributory factors.

  2004cites this paper
• Medical versus interventional management of stable angina.

  2004cites this paper
• Use of GPIIb/IIIa inhibitors in cardiovascular medicine

  2003cites this paper